Asterias Biotherapeutics to List its Series A Common Stock on NYSE MKT … – Benzinga

Asterias Biotherapeutics to List its Series A Common Stock on NYSE MKT
Benzinga
In preparation for listing on the NYSE MKT, the Company simplified its capital structure with the completion of the previously announced distribution of BioTime, Inc. common share purchase warrants to holders of Asterias Series A common stock, and with

and more

…read more

error: Content is protected !!
Scroll to Top